| Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Common Stock |
7,692,298 |
$146,153,662 |
$19.00 |
28 Jun 2021 |
Indirect |
| Trevi Therapeutics, Inc. |
10%+ Owner |
Pre-Funded Warrants |
3,000,000 |
$5,697,000 |
$1.90 |
11 Apr 2022 |
Indirect |
| Trevi Therapeutics, Inc. |
10%+ Owner |
Common Stock |
948,948 |
$1,916,875 |
$2.02 |
11 Apr 2022 |
Indirect |
| Metacrine, Inc. |
10%+ Owner |
Common Stock |
2,563,257 |
$1,204,731 |
$0.4700 |
22 Dec 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Class A Common Stock |
270 |
$3,317 |
$12.28 |
02 May 2022 |
Indirect |
| Eargo, Inc. |
10%+ Owner |
Common Stock |
821 |
$2,126 |
$2.59 |
24 May 2021 |
Indirect |
| IonQ, Inc. |
10%+ Owner |
Common Stock |
70 |
$925 |
$13.21 |
16 Nov 2022 |
Indirect |
| Arcellx, Inc. |
10%+ Owner |
Common Stock |
12 |
$663 |
$55.27 |
20 Dec 2022 |
Indirect |
| AVEO PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock |
24 |
$360 |
$15.00 |
19 Oct 2022 |
Indirect |
| Desktop Metal, Inc. |
10%+ Owner |
Class A Common Stock |
54 |
$40 |
$0.7332 |
08 Jun 2021 |
Indirect |
| Trevi Therapeutics, Inc. |
10%+ Owner |
3.5-Year Common Stock Warrant |
1,851,852 |
|
|
18 Oct 2021 |
Indirect |
| Trevi Therapeutics, Inc. |
10%+ Owner |
7-Year Common Stock Warrant |
1,851,852 |
|
|
18 Oct 2021 |
Indirect |
| Bright Health Group Inc. |
10%+ Owner |
Series A Convertible Perpetual Preferred Stock |
125,000 |
|
|
03 Jan 2022 |
Indirect |
| Bright Health Group Inc. |
10%+ Owner |
Series B Convertible Perpetual Preferred Stock |
100,000 |
|
|
17 Oct 2022 |
Indirect |
| Akouos, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$12.50 |
30 Nov 2022 |
Indirect |
| GENOCEA BIOSCIENCES, INC. |
10%+ Owner |
Common Stock |
0 |
|
$1.25 |
25 May 2022 |
Indirect |
| Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series A-2 convertible preferred stock |
0 |
|
|
28 Jun 2021 |
Indirect |
| Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series B convertible preferred stock |
0 |
|
$2.00 |
28 Jun 2021 |
Indirect |
| Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series C convertible preferred Stock |
0 |
|
$2.96 |
28 Jun 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Common Stock |
0 |
|
$34.32 |
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Series B Redeemable Convertible Preferred Stock |
0 |
|
|
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Series C Redeemable Convertible Preferred Stock |
0 |
|
|
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Series D Redeemable Convertible Preferred Stock |
0 |
|
|
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Series E Redeemable Convertible Preferred Stock |
0 |
|
|
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Series F Redeemable Convertible Preferred Stock |
0 |
|
|
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Tranche I Convertible Promissory Note |
0 |
|
|
02 Aug 2021 |
Indirect |